This Section of the Royal Society of Medicine came into being in July 1965, and one of its important functions will be to bring forth the news from the back-room boys of immunology and allergy to their clinical colleagues. I take it that we no longer believe that the allergic events which we see in man are unique to man as a species. In the sphere of auto-allergy there is no more compelling demonstration of the ability of the immunological response to result in disease than the experiment of injecting an animal (or man) with homologous tissues to cause encephalitis or other diseases, the symptoms of which correspond with the nature of the tissue used as antigen. For example, when a guinea-pig is injected with homologous brain in emulsion in so-called Freund's adjuvant it will develop fatal encephalitis at 16-25 days later. When adrenal tissue is used adrenalitis results; when thyroid is used, thyroiditis follows, when testis is used, orchitis and azoospermia occur and so on. In the guinea-pig, two components which are obligatory for the occurrence of such immunological events are the antigen and the adjuvant, and my Address is thus divided into two halves. In the first I want to consider the activity of adjuvants and in particular, the mycobacterial components which make antigens work to produce disease; in the second, I want to put forward some tentative ideas on how antigens are handled by the cells of the body to initiate an immunological response.
Chemical Nature and Immunological Role ofthe Adjuvant In general the results of injecting homologous tissue into a guinea-pig are rather unexciting in terms of pathological results, but if the injection is made in the presence of mycobacteria in mineral oil, the diseases encephalitis, thyroiditis, azoospermia, adrenalitis, &c., will follow according to the nature of the added tissue antigen. These diseases rarely, if ever, occur in the guinea-pig if the mycobacteria are omitted from the oily injection mixture. The mycobacteria are referred to as 'adjuvants'. This term envisages that they help the antigen quantitatively to give a better response, but we now know that such a concept of an adjuvant is quite inadequate to express its action.
Sometimes it appears that they even start the response. Thus an injection of, say, 1 mg of human serum albumin can be injected into a mouse without the latter either producing specific antibody or betraying subsequently that it has ever encountered such foreign molecules. In other words, this foreign protein can be metabolized by the body without the mouse developing any immunological memory for the encounter. But if a dose of mycobacteria is injected elsewhere into the mouse's body, then this will trigger off an immunological response to the HSA molecules.
Besides causing antigens to stimulate more antibody production, or even initiating this production, adjuvants act by greatly enhancing cell mediated immunity (or delayed-type hypersensitivity). A clear demonstration of this is provided, in our experiments, by the corneal test. A tiny dose of, say, ovalbumin injected into the cornea of a guinea-pig which was immunized with ovalbumin in water/mineral oil emulsion three weeks previously results in practically no change in the opacity of the cornea inspected one or two days later. However, when the same injection is made into a guinea-pig which had been sensitized by an injection of ovalbumin in the same emulsion plus mycobacteria, a corneal injection of ovalbumin is succeeded by severe thickening and opacity from the intense exudation between the corneal fibres of mononuclear inflammatory cells.
Yet another effect of the mycobacteria in immunity is to deviate the response so that new or different immunoglobulins are synthesized. In the guinea-pig, a protein antigen such as ovalbumin which is injected alone, or in simple water-in-oil I I emulsion, leads to an antibody response at three weeks which is entirely, or almost entirely, confined to the fast or y,-globulin. But when mycobacteria are added to the water-in-oil emulsion a new peak of slow or y.-globulin appears. This newly synthesized antibody is an immunoglobulin which can be dissociated by reduction, alkylation and dialysis against 0 5 M proprionic acid into light and heavy chains. The light chain appears to be the same as that from y1-globulin but the heavy chain shows differences in its Fc piece (Askonas et al. 1965 , Nussenzweig & Benacerraf 1964 .
The action of adjuvants cannot therefore be regarded as the indiscriminate stimulation of all immunological responses. Mycobacterial adjuvants appear to work specifically to increase particular immunoglobulins, especially y2-immunoglobulin in the guinea-pig. It is moreover interesting that such stimulation of y2-immunoglobulin appears to be linked with the increase in delayed-type hypersensitivity. The evidence for this is briefly as follows: (1) In carrying out a wide range of tests of adjuvant activity with different chemical extracts of mycobacteria an excellent correlation has always so far been found between ability to induce a positive corneal test and to cause the appearance ofy2-immunoglobulin in the immunoelectrophoresis of the antiserum. (2) Most other adjuvants besides mycobacteria and related micro-organisms are regarded as inducing increases in serum antibody without increasing delayed-type hypersensitivity, and such adjuvants as have been tested in the guinea-pig situation (aluminium phosphate, calcium alginate, silica, simple water-in-oil emulsions) have been found to increase y1-immunoglobulins without leading to delayed hypersensitivity sufficient to yield a positive corneal test. Nevertheless, occasionally an injection of bentonite with ovalbumin intraperitoneally has been found to be followed by production of delayed hypersensitivity (positive corneal reaction) and these same animals were found to give, on immunoelectrophoresis, a yprecipitin arc. (3) It is possible to block the activity of the Freund's complete adjuvant in giving rise to delayed hypersensitivity (Boyden 1957 ) by means of a prior injection of protein antigen in an injection lacking mycobacterial adjuvant. When this is done, it has been reported by several laboratories that the appearance of y2-immunoglobulin is similarly blocked (Asherson 1966 , Loewi et al. 1966 , Wilkinson & White 1966 ).
When we come to consider the physical and chemical nature of the active principle of mycobacteria we find that this property is shared by human, bovine and avian Mycobacterium tuberculosis, saprophytic bacteria like M. phlei and M. smegmatis and atypical mycobacteria such as M. kansasii. Also Nocardia species (N. asteroides and N. rhodochrous) and some but definitely not all Corynebacteria species, e.g. C. rubrum which may, however, be identical with N. rhodochrous (Gordon 1966) . Early work by Raffel (1950) had shown that mycobacteria deprived of their lipids by means of chloroform extraction in acid lost their ability to induce tuberculin hypersensitivity; and a lipid substance, so called wax D, could be extracted from the human strain of Mycobacterium tuberculosis (Asselineau & Lederer 1953) which, when mixed with tuberculoprotein, would induce tuberculin hypersensitivity. Our later work showed that wax D was active as an adjuvant in increasing antibody levels (White et al. 1955 ), delayed-type hypersensitivity and facilitating the production of allergic disseminated encephalomyelitis (White & Marshall 1958 ). However, it soon became apparent that not all of the wax D fractions of mycobacteria were active (White et al. 1958) . Whereas wax D from all human strains was uniformly active as adjuvants, wax D from bovine or avian strains of M. tuberculosis and from the saprophytic strains M. phlei and M. smegmatis were all inactive although the whole killed bacilli from the same organisms were fully active. The difference correlated with the fact that the chromatographs of hydrolysed adjuvant-active wax D preparations always gave prominent spots of three amino acids: alanine (D and L), glutamic acid (L) and meso-a, E-diaminopimelic acid. The surprising difference between human and bovine wax Ds became further clarified by centrifugation of whole wax D in ether by the method of Jolles et al. (1962) . Treated in this way, wax D fractions from human types of M. tuberculosis were found to be mainly sedimenting peptidoglycolipids with only 10-15 % of nonsedimenting glycolipid. In the case of bovine and avian strains of M. tuberculosis and saprophytic mycobacteria their wax D was found to be composed principally of biologically inactive glycolipid, with only a low proportion of biologically active peptidoglycolipid. The subfractions of wax D obtained by centrifugation in ether suspensions were found to possess increased activity. The rapidly sedimenting Dp7O fraction (obtained after 70 minutes of centrifugation) is about ten times more active than the slowly sedimenting Dpl50 fraction, and is about four times more active than heat-killed, dried whole Mycobacterium tuberculosis .
By means of negatively-stained preparations in the electron microscope, the adjuvant-active rapidly sedimenting peptidoglycolipids appear as (Fig 1) . The nonsedimenting glycolipid (which lacks amino sugars and amino acids and has no adjuvant biological activity) had an appearance very like plant cellulose, i.e. very fine parallel filaments about 40 A wide, which are aggregated with branching and intersecting bundles. In the case of whole mycobacteria, the 133 A peptidoglycolipid fibres appear to ramify over the cell wall (Fig 2) . Chemically, this lipid macromolecule (molecular weight estimations vary from 30,000 to 54,000) appears as a ,3 hydroxy branched chain C78 fatty acid esterified with a glycopeptide (molecular weight 26,000). This peptidoglycolipid has striking analogies in its chemical structure to bacterial cell-wall mucopeptides. Such a mucocomplex is characterized by the following organic constituents: hexosamines (glucosamine, muramic acid, galactosamine), peptides of a few amino acids which include alanine, glutamic acid and either diaminopimelic acid or lysine, and a polysaccharide containing not more than four sugar residues. All these elements are present in the adjuvant-active peptidoglycolipids. They also resemble bacterial cell walls in possessing 'unnatural' amino acids of the Dconfiguration, which are restricted in nature to cell walls and some extracellular products of bacteria, such as antibiotics and slime layers.
Our concepts of how such a bizarre molecule could affect the immunological response are at present hampered by our ignorance of how an antigen exerts its stimulation of the response. However, I believe that two properties may be significant for adjuvant activity. First, the intact molecule of peptidoglycolipid would be expected to be highly surface-active. It easily hydrolyses with acid or alkali to the lipophilic mycolic acid and the hydr6philic glycopeptide. Neither of these products have adjuvant activity. Gall (1966) , surveying a large number of organic compounds as adjuvants, came to the conclusion that activity depended on a combination of basicity and a long aliphatic chain of twelve or more carbon atoms. Activity was thus suggested to link with surface activity and ability to concentrate at and alter cell membranes. Secondly, the glycopeptide moiety possesses a strong affinity for protein of the y-globulin type (Stewart-Tull et al. 1965 ). Thus guinea-pig y2-immunoglobulin will take up mycobacterial glycopeptide so that it comes to make up 40 % of the whole.
Recent Work on the Cellular Reception ofAntigens
The major problem in immunogenicity is to arrange for liaison between the antigen entering the spleen by the blood (or the nodes by the afferent lymph) and the immunologically competent cells which are able to react to it. By draining off the lymphocytes from the thoracic duct of a rat, Gowans et al. (1962) removed the ability of the animal to give a primary response, and subsequently restored this ability with a population of virtually pure small lymphocytes. Hence, we can restate the problem more precisely as arranging a liaison between antigen entering via the afferent lymph and some members of a mobile population of small lymphocytes continually passing through the nodeout of the blood via the post-capillary venules into the white pulp and back to the blood via the efferent lymph (Gowans & Knight 1964) . The principal cells subsequently making the antibody are plasma cells situated usually and mainly in the draining regional nodes. Therefore it is suggested that the effective antigen must be halted within the regional node and held there for some days or even weeks so that circulating immunologically competent lymphocytes can make contact and settle locally. We therefore need a 'net for circulating lymphocytes'. I should like to refer to some experiments using human serum albumin (HSA) and other proteins as antigens in the chicken, which were started by me in 1962 and continued more recently in Glasgow with the help of Dr Marshall Stark and Dr Valentine French. After an injection of l-10 mg of HSA intravenously the chicken of 6-10 weeks produces a rapid antibody response, which appears to be associated in time with the presence of differentiating families of plasma cells in the red pulp of the spleen. However, another and quite distinct morphological reaction is the development in the white pulp of the cellular proliferations known as germinal or lymphocytopoietic centres. These become visible first at four days after antigen injection as small, rounded foci of dividing cells which are slightly larger, with more basophilic cytoplasm and more open, larger nuclei than the surrounding small lymphocytes of the white pulp. Mitotic figures are prominent in such foci which between four and seven days enlarge rapidly into sharply demarcated spherical collections of medium and large lymphocytes.
When such a centre, at the sixth day of its development, is stained by a single layer of fluorescent anti-HSA antibody (to reveal the cellular distribution of antigen) we obtain the striking appearance (Fig 3) of fluorescence outlining the spindle-shaped perikarya and dendritic processes of cells which are scattered rather evenly over the germinal centre so as to be separated from one another by other nonfluorescent cells. It was on the basis of these appearances that I called such antigen-bearing cells dendritic cells (White 1963) . Preliminary work had shown that metalophilic cells (Weil-Davenport method) can occur in a similar pattern in germinal centres and it was envisaged that such cells might be akin to the microglia and other metalophilic precursors of macrophages (Marshall 1956) .
The evidence that we have indicates that such localization of antigen is dependent on circulating antibody and that what we see associated with dendritic cells are really antigen-antibody complexes rather than antigen alone. The evidence for Section of Clinical Immunology and Allergy 5 *-2+ ' ¢*11 1 centres. Autoradiographs prepared by Dr Marshall Stark, using '211-labelled HSA show that this initial localization is to cells which are l'A .
grouped around the ellipsoids at the margin of the iJ s l, 6 4 l g white and red pulp and, rather more densely, 1 ! z g*>¢+# =11 J1 1 ! f : around the branches of the central artery of the white pulp. None is present along the central arteriole itself. The earliest formation of germinal centres seems to occur at three days, appearing in the autoradiographs as small aggregations of dendritic cells between the branching arms of the central arteriole (Fig 4) . Between the third and sixth days after a single antigen injection the process of formation of germinal centres appears to involve more and more of the antigen-bearing cells so that at six days none is present outside centres (Fig 5) . .V_ 9 _ The appearances suggest that we are witnessing a progressive netting of immunologically competent lymphocytes by dendritic cells as they pass through the white pulp of the spleen. The initial formation of the germinal centre could, therefore, represent an agglutinative reaction between antigen-bearing dendritic cells and small lymphocytes m : <t q with antibody at their surface. The demonstration by Sell & Gell (1965) (2) The localization of antigen coincides in time with the demonstrable presence of soluble com-X plexes of HSA/anti-HSA in the serum of the bird. There is no localization of antigen to dendritic cells during the first 24 hours and the build-up of antigen appears to take place from the second to the fifth day after injection. (3) Use of a fluorep scein-labled anti-chicken globulin conjugate shows an identical pattern of dendritic cells. The same result is given by a specific anti-chicken IgG (and by a specific anti-chicken IgM) which would --indicate that both these immunoglobulins participate in the localizatioin to dendritic cells.
When the localization of antigen is studied at the earliest time intervals after a single antigen in- Fig can induce transformation of rabbit lymphocytes to dividing pyroninophilic cells (large lymphocytes) indicates at least that available immunoglobulin is present at the lymphocyte surface. However, in the germinal centre reaction, antigen reacting with homologous antibody would be the stimulus for transformation, and the pyroninophilia and mitotic division of the germinal centre would be the natural consequence. By the fluorescence method for detecting antigen, the presence of antigen-bearing dendritic cells in germinal centres can be seen at least up to 16 days following antigen injection (1 mg HSA). Use of a sandwich fluorescent-antibody method reveals that from about day 13 some of these cells show a cytoplasmic content of antibody and some centres show almost all their cells with a faint fluorescence denoting the presence of antibody. Of course, by an agglutinative process like the one suggested, the initially incorporated cells must be immunologically competent cells of a specificity corresponding to the injected antigen. The resultant large ball of multiplied lymphocytes must all presumably consist of cells bearing the same specificity. The demonstration of antibody in almost all the cells of some centres is at least consistent with this deduction (Fig 6) .
To summarize, I have presented findings as they appear to relate to both antigen and adjuvant. The properties of both must play their role in immu-nogenicity. The surface-active properties of the mycobacterial peptidoglycolipid, as well as of mainy other adjuvants would demand a surface for their activity. Based on his demonstration that intracellular release of phagosomal or lysosomal enzymes can cause nuclear chromosomal damage, A E Allison (1966, personal communication) has suggested that adjuvants, e.g. silica and bacterial endotoxin, may act at the lysosomal surface. However, adjuvant activity would appear to require more than the mere provision of a lipidsoluble substance which precipitates lysosomal rupture, since high concentrations of vitamin A in mineral oil fail to act as an immunological adjuvant'. Another surface which we should investigate is that of the dendritic cells. Peptidoglycolipid might increase the capture or persistence of antigen at such sites. We have argued above that this adjuvant acts specifically to stimulate the processes of y2-immunoglobulin synthesis in the guinea-pig, and shown (Stewart-Tull et al. 1965 ) that the glycopeptide moiety of the adjuvant has a high affinity for this immunoglobulin. The adjuvant peptidoglycolipid in wax D from Mycobacterium tuberculosis may therefore form the bird-lime which holds the lymphocytes more effectively in the net of dendritic cells.
